Boehringer Ingelheim (Netherlands)
- Research works
- 57 ▼ 15% vs 2013–17
- Citations
- 2.3k 41.1 per fractional work
- Top-10% rate
- 10.6% record average 16.5%
- Open access
- 46% world 28%
Not ranked overall: Boehringer Ingelheim (Netherlands) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 7.8×. Every wedge is a field page.
- Veterinary 7.8×
- Immunology and Microbiology 6.0×
- Medicine 2.9×
- Computer Science 1.4×
- Business, Management and Accounting 1.1×
- Economics, Econometrics and Finance 1.1×
- Agricultural and Biological Sciences 0.9×
- Engineering 0.5×
- Arts and Humanities 0.4×
- Psychology 0.4×
- Social Sciences 0.4×
- Health Professions 0.3×
- Biochemistry, Genetics and Molecular Biology 0.1×
Which keywords describe research at Boehringer Ingelheim (Netherlands)?
By fractional works in all years, weighted toward what it does more of than the world: Treatment, Epidemiology, Diagnosis, Inflammation, Heart Failure, Glycemic Control, Management and Insulin Therapy.
- Medical Ethics
- Antithrombotic Therapy
- Pathogenesis
- Diabetes Mellitus
- Guidelines
- Glucose Control
- Health Utility Measures
- Type 2 Diabetes
- Idiopathic Pulmonary Fibrosis
- TGF-ß
- Interstitial Lung Disease
- Pulmonary Drug Delivery
- Fibrosis
- Allergic Diseases
- Clinical Guidelines
- Global Burden
- Insulin Therapy
- Heart Failure
- Diagnosis
- Treatment
- Epidemiology
- Inflammation
- Glycemic Control
- Management
- Asthma
- Cardiovascular Disease
- Genetics
- Eosinophils
- Inhaler Devices
- COPD
- Quality of Life
- spirometry
- Myofibroblast
- Cost-effectiveness Analysis
- Cardiovascular Outcomes
- Clinical Trials
- Clinical Practice Guidelines
- Hemostasis
- Microcirculation
- Genetic Testing
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology8▲ 3.3×18 topics
- Treatment6▲ 7.9×7 topics
- Inflammation5▲ 3.7×17 topics
- Diagnosis4▲ 7.4×5 topics
- Glycemic Control3▲ 44×4 topics
- Heart Failure3▲ 13×5 topics
- Management3▲ 7.7×5 topics
- Insulin Therapy3▲ 53×3 topics
- Asthma3▲ 44×2 topics
- Global Burden3▲ 11×5 topics
- Cardiovascular Disease3▲ 4.9×15 topics
- Clinical Guidelines3▲ 17×5 topics
- Genetics3▲ 7.1×2 topics
- Allergic Diseases3▲ 68×1 topic
- Eosinophils3▲ 68×1 topic
- Fibrosis3▲ 26×4 topics
- Inhaler Devices3▲ 154×1 topic
- Pulmonary Drug Delivery3▲ 154×1 topic
- COPD2▲ 70×1 topic
- Interstitial Lung Disease2▲ 80×2 topics
- Quality of Life2▲ 3.2×7 topics
- TGF-ß2▲ 25×3 topics
- spirometry2▲ 70×1 topic
- Idiopathic Pulmonary Fibrosis2▲ 103×1 topic
- Myofibroblast2▲ 103×1 topic
- Type 2 Diabetes2▲ 19×2 topics
- Cost-effectiveness Analysis2▲ 43×1 topic
- Health Utility Measures2▲ 43×1 topic
- Cardiovascular Outcomes2▲ 76×1 topic
- Glucose Control2▲ 76×1 topic
- Clinical Trials2▲ 4.5×5 topics
- Guidelines2▲ 5.8×4 topics
- Clinical Practice Guidelines2▲ 4.7×5 topics
- Diabetes Mellitus1▲ 11×4 topics
- Hemostasis1▲ 16×2 topics
- Pathogenesis1▲ 4.5×4 topics
- Microcirculation1▲ 29×2 topics
- Antithrombotic Therapy1▲ 20×2 topics
- Genetic Testing1▲ 13×2 topics
- Medical Ethics1▲ 12×2 topics
Which research topics does Boehringer Ingelheim (Netherlands) publish most on?
By volume in 2022–2025: Diabetes Treatment and Management, Inhalation and Respiratory Drug Delivery, Hyperglycemia and glycemic control in critically ill and hospitalized patients and Augmented Reality Applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
- 2 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 1 works
- 3 Hyperglycemia and glycemic control in critically ill and hospitalized patients Endocrinology, Diabetes and Metabolism 0 works
- 4 Augmented Reality Applications Computer Vision and Pattern Recognition 0 works
- 5 Edcuational Technology Systems Artificial Intelligence 0 works
- 6 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 0 works
- 7 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 0 works
- 8 Manufacturing Process and Optimization Industrial and Manufacturing Engineering 0 works
- 9 Business Process Modeling and Analysis Management Information Systems 0 works
- 10 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Boehringer Ingelheim (Netherlands)'s research output changed?
Output in 2018–2022 was 15% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Alkmaar
- Medisch Centrum Alkmaar
- B. Braun (Netherlands)
- Noordwest Ziekenhuisgroep
- Podocentrum Alkmaar
- Centrum Oosterwal
- Teamwork Technology (Netherlands)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.